|
|
|
|
Existing and emerging technologies/markets for Nasal, Pulmonary and Ophtalmic Drug Delivery
Conférence :Pharmapack 2011
|
|
|
| |
Auteur(s)/Conférencier : Gerallt Williams |
|
|
|
|
Determination of volatile organic compounds from the Prohaler® Dry Powder Inhaler
Conférence :Drug Delivery to the Lungs 21
|
|
|
| |
Auteur(s)/Conférencier : Gerallt Williams |
|
|
|
|
Comparison of Next Generation Impactor and Fast-Screening Impactor for determining fine particle fraction of dry powder inhalers
Conférence :Drug Delivery to the Lungs 21
|
|
|
| |
Auteur(s)/Conférencier : Gerallt Williams |
|
|
|
|
Influence of lactose particle size on fluticasone propionate agglomerate size within interactive mixtures for dry powder inhalers
Conférence :APGI
|
|
|
| |
Auteur(s)/Conférencier : Emmanuelle Robins (Aptar Pharma), V.N.P. Le, M-P. Flament (Université Lille Nord de France) |
|
|
|
|
Influence of powder mixing process on agglomerate behaviour of fluticasone propionate within dry powder inhalers formulations
Conférence :APGI
|
|
|
| |
Auteur(s)/Conférencier : Emmanuelle Robins (Aptar Pharma), V.N.P. Le, M-P. Flament (Université Lille Nord de France) |
|
|
|
|
Computational X-Ray tomography techniques as development tools for nasal & pulmonary device optimisation
Conférence :Respiratory Drug Delivery 2010
|
|
|
| |
Auteur(s)/Conférencier : Gerallt Williams |
|
|
|
|
EPAG Perspective - Regulatory advances related to nasal spray pumps
Conférence :Nasal Drug Delivery 2010
|
|
|
| |
Auteur(s)/Conférencier : Gerallt Williams |
|
|
|
|
Influence of the lactose grade within Dry Powder Formulations
Conférence :7th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology
|
|
|
| |
Auteur(s)/Conférencier : Emmanuelle Robins (Valois Pharma), V.N.P. Le, H. Bierend, H. Steckel, M-P. Flament (Université Lille Nord de France) |
|
|
|
|
Think Lateral ! Valois Pharma Side Actuated Nasal Spray Device
Conférence :Pharmapack 2010
|
|
|
| |
Auteur(s)/Conférencier : Hervé Pacaud |
|
|
